Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-14T16:19:55.560Z Has data issue: false hasContentIssue false

Effectiveness of cardiac surgery in patients with trisomy 18: a single-institutional experience

Published online by Cambridge University Press:  28 January 2016

Yosuke Nakai*
Affiliation:
Department of Cardiovascular Surgery, Nagoya City University Graduate School of Medical Sciences, Mizuho-ku, Nagoya, Japan
Miki Asano
Affiliation:
Department of Cardiovascular Surgery, Nagoya City University Graduate School of Medical Sciences, Mizuho-ku, Nagoya, Japan
Norikazu Nomura
Affiliation:
Department of Cardiovascular Surgery, Nagoya City University Graduate School of Medical Sciences, Mizuho-ku, Nagoya, Japan
Hidekazu Matsumae
Affiliation:
Department of Cardiovascular Surgery, Nagoya City University Graduate School of Medical Sciences, Mizuho-ku, Nagoya, Japan
Akira Mishima
Affiliation:
Department of Cardiovascular Surgery, Nagoya City University Graduate School of Medical Sciences, Mizuho-ku, Nagoya, Japan
*
Correspondence to: Y. Nakai, MD, Department of Cardiovascular Surgery, Nagoya City University Graduate School of Medical Sciences; 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan. Tel: +81 52 853 8099; Fax: +81 52 851 7201; E-mail: yo.nakai1025@gmail.com

Abstract

Background

Surgical repair for cardiac lesions has rarely been offered to patients with trisomy 18 because of their very short lifespans. We investigated the effectiveness of cardiac surgery in patients with trisomy 18.

Patients and methods

We performed a retrospective analysis of 20 consecutive patients with trisomy 18 and congenital cardiac anomalies who were evaluated between August, 2003 and July, 2013. All patients developed respiratory or cardiac failure due to excessive pulmonary blood flow. Patients were divided into two subgroups: one treated surgically (surgical group, n=10) and one treated without surgery (conservative group, n=10), primarily to compare the duration of survival between the groups.

Results

All the patients in the surgical group underwent cardiac surgery with pulmonary artery banding, including patent ductus arteriosus ligation in nine patients and coarctation repair in one. The duration of survival was significantly longer in the surgical group than in the conservative group (495.4±512.6 versus 93.1±76.2 days, respectively; p=0.03). A Cox proportional hazard model found cardiac surgery to be a significant predictor of survival time (risk ratio of 0.12, 95% confidence interval 0.016–0.63; p=0.01).

Conclusions

Cardiac surgery was effective in prolonging survival by managing high pulmonary blood flow; however, the indication for surgery should be carefully considered on a case-by-case basis, because the risk of sudden death remains even after surgery. Patients’ families should be provided with sufficient information to make decisions that will optimise the quality of life for both patients and their families.

Type
Original Articles
Copyright
© Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Baty, BJ, Blackburn, BL, Carey, JC. Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk. Am J Med Genet 1994; 49: 175188.CrossRefGoogle ScholarPubMed
2. Embleton, ND, Wyllie, JP, Wright, MJ, Burn, J, Hunter, S. Natural history of trisomy 18. Arch Dis Child Fetal Neonatal Ed 1996; 75: F38F41.CrossRefGoogle ScholarPubMed
3. Van Dyke, DC, Allen, M. Clinical management considerations in long-term survivors with trisomy 18. Pediatrics 1990; 85: 753759.Google Scholar
4. Rasmussen, SA, Wong, LYC, Yang, QY, May, KM, Friedman, JM. Population-based analysis of mortality in trisomy 13 and trisomy 18. Pediatrics 2003; 111: 777784.CrossRefGoogle ScholarPubMed
5. Graham, EM, Bradley, SM, Shirali, GS, Hills, CB, Atz, AM. Effectiveness of cardiac surgery in trisomies 13 and 18 (from the Pediatric Cardiac Care Consortium). Am J Cardiol 2004; 93: 801803.Google Scholar
6. Muneuchi, J, Yamamoto, J, Takahashi, Y, et al. Outcomes of cardiac surgery in trisomy 18 patients. Cardiol Young 2011; 21: 209215.Google Scholar
7. Kobayashi, J, Kaneko, Y, Yamamoto, Y, Yoda, H, Tsuchiya, K. Radical surgery for ventricular septal defect associated with trisomy 18. Gen Thorac Cardiovasc Surg 2010; 58: 217219.Google Scholar
8. Suzuki, E, Oshima, Y, Doi, Y, et al. Four cases of open-heart surgery in infants with trisomy 13 or trisomy 18. Pediatr Cardiol Cardiovasc Surg 2008; 24: 546554; (in Japanese).Google Scholar
9. American Heart Association, American Academy of Pediatrics. 2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: neonatal resuscitation guidelines. Pediatrics 2006; 117: e1029e1038.CrossRefGoogle Scholar
10. Carter, PE, Pearn, JH, Bell, J, Martin, N, Anderson, NG. Survival in trisomy 18: life tables for use in genetic counseling and clinical paediatrics. Clin Genet 1985; 27: 5961.CrossRefGoogle ScholarPubMed
11. Goldstein, H, Nielsen, KG. Rates and survival of individuals with trisomy 13 and trisomy 18: data from a 10-year period in Denmark. Clin Genet 1988; 34: 366372.Google Scholar
12. Niedrist, D, Riegel, M, Achermann, J, Schinzel, A. Survival with trisomy 18: data from Switzerland. Am J Med Genet 2006; 140: 952959.Google Scholar
13. Van Praagh, S, Truman, T, Firpo, A, et al. Cardiac malformations in trisomy-18: a study of 41 postmortem cases. J Am Coll Cardiol 1989; 13: 15861597.CrossRefGoogle ScholarPubMed
14. Balderston, SM, Shaffer, EM, Washington, RL, Sondheimer, HM. Congenital polyvalvular disease in trisomy 18: echocardiographic diagnosis. Pediatr Cardiol 1990; 11: 138142.CrossRefGoogle ScholarPubMed
15. Kinoshita, M, Nakamura, Y, Nakano, R, et al. Thirty-one autopsy cases of trisomy 18: clinical features and pathological findings. Pediatr Pathol 1989; 9: 445457.CrossRefGoogle ScholarPubMed
16. Kosho, T, Nakamura, T, Kawame, H, Baba, A, Tamura, M, Fukushima, Y. Neonatal management of trisomy 18: details of 24 patients receiving intensive treatment. Am J Med Genet 2006; 140: 937944.Google Scholar
17. Kaneko, J, Kobayashi, J, Achiwa, I, et al. Cardiac surgery in patients with trisomy 18. Pediatr Cardiol 2009; 30: 729734.Google Scholar
18. Maeda, J, Yamagishi, H, Furutani, Y, et al. The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan. Am J Med Genet 2011; 155: 26412646.Google Scholar
19. Allpress, AL, Rosenthal, GL, Goodrich, KM, Lupinetti, FM, Zerr, DM. Risk factors for surgical site infections after pediatric cardiovascular surgery. Pediatr Infect Dis J 2004; 23: 231234.Google Scholar
20. Numa, A, Butt, W. Mee RBB. Outcome of infants with birthweight 2000 g or less who undergo major cardiac surgery. J Pediatr Child Health 1992; 28: 318320.Google Scholar
21. Ryan, T, Mc Carthy, JF, Rady, MF, et al. Early bloodstream infection after cardiopulmonary bypass: frequency rate, risk factors, and implications. Crit Care Med 1997; 25: 20092014.Google Scholar
22. Van de Watering, LM, Hermans, J, Houbiers, JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998; 97 (562): 568.Google Scholar
23. Mangram, AJ, Horan, TC, Pearson, ML, Silver, LC, Jarvis, WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20: 250278.CrossRefGoogle ScholarPubMed
24. Kouchoukos, NT, Blackstone, EH, Doty, DB, Hanley, FL, Karp, RB. Kirklin/Barratt-Boyes Cardiac Surgery: Morphology, Diagnostic Criteria, Natural History, Techniques, Results, and Indication, 3rd edn. Churchill Livingstone, Philadelphia, PA, 2003: 66130.Google Scholar